Should You Buy Vyome Holdings Inc (HIND) Today? Analysis, Price Targets, and 2026 Outlook.
Conclusion
Hold
Latest Price
2.140
1 Day change
-15.75%
52 Week Range
62.720
Analysis Updated At
2026/01/29
Not a good buy right now for a beginner long-term investor with $50k–$100k who is impatient. The stock is in a clear downtrend (bearish moving averages) and just experienced a sharp selloff (regular market -22.09% with weak pre-market follow-through). With no supportive proprietary signals, no news catalysts, and very weak latest-quarter fundamentals (revenue collapse and large losses), the risk/reward is unfavorable to initiate a long-term position at this moment.
Technical Analysis
Trend/price action: Strongly bearish near-term. The stock closed at 2.57 after a large decline (regular market -22.09%). It is trading below the Pivot (3.117) and slightly below S1 (2.594), indicating a breakdown area; next notable support is S2 at 2.271.
Momentum: RSI_6 at 30.743 is near oversold/low-momentum territory (can allow for bounces, but does not reverse a trend by itself). MACD histogram is positive (0.0406) but positively contracting, suggesting bullish momentum is fading rather than strengthening.
Moving averages: Bearish structure (SMA_200 > SMA_20 > SMA_5) confirms the broader downtrend and argues against a long-term entry right now.
Pattern-based forward bias (provided): 40% probability points to -1.9% next day and -2.34% next week, with a +7.89% next-month bounce potential—this skews more toward a short-term rebound attempt than a clean long-term buy setup.
**Intellectia Proprietary Trading Signals**
- [AI Stock Picker](module://ai_stock_pick): no signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock recently.
Options Data
Positive Catalysts
and a post-market uptick (+1.18%) can sometimes precede a short-term technical rebound.
Neutral/Negative Catalysts
Major recent drawdown (-22.09% regular session; -17.18% pre-market) signals heavy selling pressure.
Technical trend remains bearish (SMA_200 > SMA_20 > SMA_5), and price is below pivot and key levels.
No recent news in the past week to serve as an event-driven catalyst.
Hedge funds and insiders show neutral activity (no supportive accumulation signal).
No proprietary buy signals (AI Stock Picker / SwingMax) to override the weak tape.
Financial Performance
Latest reported quarter: 2025/Q3. Revenue dropped to 34,627 (-98.49% YoY), indicating a severe contraction. Net income was -8,433,811 (reported as +433.45% YoY, but still a large loss). EPS fell to -3.06 (-99.02% YoY). Gross margin decreased to 44.02 (-29.88% YoY). Overall: weakening operating picture with extreme revenue decline and continued losses—poor support for a long-term beginner-friendly entry right now.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data was provided, so a Wall Street consensus view cannot be confirmed from the dataset. Based on the available data (trend + financials), the visible pros are limited to potential oversold bounce, while the cons dominate (downtrend and severe revenue decline).
Wall Street analysts forecast HIND stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HIND is 15 USD with a low forecast of 15 USD and a high forecast of 15 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast HIND stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HIND is 15 USD with a low forecast of 15 USD and a high forecast of 15 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.